ArticleCardiology and cardiovascular medicine2026
Rapid Treatment of Acute Decompensated Heart Failure with Cardiogenic Shock in the Emergency Setting.
Article in Cardiology and cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Acute decompensated heart failure accounts for more than a million United States hospitalizations each year, and its most severe expression, cardiogenic shock, carries an in-hospital mortality approaching fifty percent. Most randomized evidence in heart failure concerns the chronic outpatient population, which leaves the emergency department phase, during which a large share of the eventual trajectory is determined, supported by comparatively few dedicated trials. This review draws together what is currently known about the recognition and early stabilization of acute decompensated heart failure complicated by cardiogenic shock in the emergency setting. It describes the shock spiral, in which falling cardiac output lowers coronary perfusion pressure and further impairs contractility, together with the inflammatory component that explains why a subset of patients present with an inappropriately low systemic vascular resistance. It reviews bedside phenotyping along the axes of perfusion and congestion, severity staging with the SCAI SHOCK classification, and the diagnostic tools available at the bedside, including point-of-care ultrasound of the lungs, heart, and inferior vena cava, the electrocardiogram as a means of identifying the precipitating arrhythmia, and the laboratory markers of perfusion and end-organ stress. The management section argues that sequence is itself a therapeutic decision: perfusion pressure is restored first, contractility second, and congestion third, because each intervention is actively harmful when performed out of order. Non-invasive ventilation, rate and rhythm management, and correction of anemia are addressed as parallel contributors to oxygen delivery. The review closes with criteria for escalation to mechanical circulatory support and multidisciplinary shock team care, and states plainly the unequal quality of the evidence supporting each recommendation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.